Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Allogeneic Cell Therapy Market Size From 2025 to 2034?
The market size of allogeneic cell therapy has seen swift expansion in the past few years. Projected to increase from $1.08 billion in 2024 to $1.2 billion in 2025, the compound annual growth rate (CAGR) is set at 11.5%. The surge during the historic period is a result of heightened emphasis on customizing donor cell choices and genetic alterations, population growth, a rise in the worldwide impact of chronic illnesses, heightened awareness, and an upswing in partnership initiatives for biosimilar development.
The market size of allogeneic cell therapy is predicted to witness significant expansion in the upcoming years, reaching $1.81 billion by 2029 at a compound annual growth rate (CAGR) of 10.8%. This growth within the projected period is fostered by factors like increasing demand for high quality medical care, growing interest in fresh allogeneic cell treatments, escalating number of clinical tests, major contributions by expanding patient population, and soaring income levels. The forecast period is also expected to showcase major shifts such as advancement in technology, relationship formations among firms, collaborations of prominent companies, mergers and captures, and unveiling of new products.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp
What Are the Core Market Drivers Propelling Growth in the Allogeneic Cell Therapy Industry?
The anticipated surge in chronic diseases is likely to contribute to the expansion of the allogeneic cell therapy market. These long-term conditions often necessitate consistent medical care and can impede day-to-day activities or quality of life. The rise in chronic illnesses can be attributed to lifestyle changes, genetic predisposition, and exposure to harmful chemicals, toxins, and pollutants. Allogeneic cell therapy, which uses healthy cells from a donor to repair, replace, or modify non-functional cells or tissues in the recipient, offers immense potential for the treatment of diverse chronic diseases. For example, the National Center for Biotechnology Information (NCBI), a US-based medical library, predicted in January 2023 that the number of individuals over 50 suffering from one or more chronic diseases will grow by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Consequently, the escalating prevalence of chronic conditions propels the allogeneic cell therapy market’s growth.
How Is the Allogeneic Cell Therapy Market Segmented?
The allogeneic cell therapymarket covered in this report is segmented –
1) By Type: Stem Cell Therapies; Non-Stem Cell Therapies
2) By Therapeutic Area: Hematological Disorders; Dermatological Disorders; Other Therapeutic Area
3) By End User: Hospitals; Specialty Clinics; Research Organizations
Subsegments:
1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells); Mesenchymal Stem Cell Therapy (MSC-Based Therapies); Induced Pluripotent Stem Cells (iPSC-Based Therapies); Neural Stem Cell Therapy; Other Stem Cell Therapies
2) By Non-Stem Cell Therapies: T-cell Therapies; Natural Killer (NK) Cell Therapies; Dendritic Cell Therapies; Other Non-Stem Cell Therapies
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15976&type=smp
Which Regions Are Driving the Next Phase of the Allogeneic Cell Therapy Market Growth?
North America was the largest region in the allogeneic cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Allogeneic Cell Therapy Industry?
Leading firms in the allogeneic cell therapy market are concentrating on the creation of innovative solutions, including cell processing platforms, to bolster their market presence. Cell processing platforms are technologies and systems designed for cell preparation and manipulation for therapeutic utilize, combining isolation, purification, expansion, modification, and quality control to warrant cell suitability for clinical use. For instance, in March 2024, Getinge, a healthcare company based in Sweden, collaborated with CellRev, a biotech firm from the UK, to unveil Livit ACE, a continuous cell processing platform for Adherent Cell Expansion. This revolutionary platform uses advanced automation and bioprocessing technologies to greatly improve the scalability and efficiency of cell production. It has unique functionalities such as cutting-edge cell isolation and purification systems assuring high levels of cell purity and viability, robust expansion capabilities for extensive therapeutic cell production, intricate genetic alteration tools for accurate cell engineering, and stringent quality control procedures to assure the safety and effectiveness of the cell products.
View the full report here:
https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report
How Is the Allogeneic Cell Therapy Market Defined and What Are Its Core Parameters?
Allogeneic cell therapy is a treatment in which cells are harvested from a donor and used to treat a different individual (the recipient). These therapies are designed to replace or repair damaged tissues, modulate immune responses, or treat diseases such as cancer, genetic disorders, and autoimmune conditions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15976
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model